Pacemaker Implantation and Dependency After Transcatheter Aortic Valve Replacement in the REPRISE III Trial

Author:

Meduri Christopher U.1,Kereiakes Dean J.2,Rajagopal Vivek1,Makkar Raj R.3,O'Hair Daniel4,Linke Axel5,Waksman Ron6,Babliaros Vasilis7,Stoler Robert C.8,Mishkel Gregory J.9,Rizik David G.10,Iyer Vijay S.11,Schindler John12,Allocco Dominic J.13,Meredith Ian T.13,Feldman Ted E.1415,Reardon Michael J.16

Affiliation:

1. Piedmont Heart Institute Atlanta GA

2. The Christ Hospital Heart and Vascular Center The Lindner Research Center Cincinnati OH

3. Cedars—Sinai Heart Institute Los Angeles CA

4. Aurora St. Luke's Medical Center Milwaukee WI

5. Dresden University Hospital, Heart Center Dresden Germany

6. Washington Hospital Center Washington DC

7. Emory University Hospital Emory University Atlanta GA

8. Baylor Heart & Vascular Hospital Dallas TX

9. St. John's Hospital Springfield IL

10. HonorHealth and the Scottsdale‐Lincoln Health Network Scottsdale AZ

11. University at Buffalo/Gates Vascular Institute Buffalo NY

12. University of Pittsburgh Medical Center Pittsburgh PA

13. Boston Scientific Corp Marlborough MA

14. Edwards Lifesciences Irvine California

15. Northshore University Health System Evanston Hospital Evanston Illinois

16. Houston Methodist DeBakey Heart and Vascular Center Houston TX

Abstract

Background As transcatheter aortic valve replacement expands to younger and/or lower risk patients, the long‐term consequences of permanent pacemaker implantation are a concern. Pacemaker dependency and impact have not been methodically assessed in transcatheter aortic valve replacement trials. We report the incidence and predictors of pacemaker implantation and pacemaker dependency after transcatheter aortic valve replacement with the Lotus valve. Methods and Results A total of 912 patients with high/extreme surgical risk and symptomatic aortic stenosis were randomized 2:1 (Lotus:CoreValve) in REPRISE III (The Repositionable Percutaneous Replacement of Stenotic Aortic Valve through Implantation of Lotus Valve System—Randomized Clinical Evaluation) trial. Systematic assessment of pacemaker dependency was pre‐specified in the trial design. Pacemaker implantation within 30 days was more frequent with Lotus than CoreValve. By multivariable analysis, predictors of pacemaker implantation included baseline right bundle branch block and depth of implantation; diabetes mellitus was also a predictor with Lotus. No association between new pacemaker implantation and clinical outcomes was found. Pacemaker dependency was dynamic (30 days: 43%; 1 year: 50%) and not consistent for individual patients over time. Predictors of pacemaker dependency at 30 days included baseline right bundle branch block, female sex, and depth of implantation. No differences in mortality or stroke were found between patients who were pacemaker dependent or not at 30 days. Rehospitalization was higher in patients who were not pacemaker dependent versus patients without a pacemaker or those who were dependent. Conclusions Pacemaker implantation was not associated with adverse clinical outcomes. Most patients with a new pacemaker at 30 days were not dependent at 1 year. Mortality and stroke were similar between patients with or without pacemaker dependency and patients without a pacemaker. Clinical Trial Registration URL : https://www.clinicaltrials.gov/ . Unique identifier NCT 02202434.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cardiology and Cardiovascular Medicine

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3